Search
for
Sort by
Research 91–120 of 1000+
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials
- P123 : Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and metaanalysis
- Excellent response to tofacitinib treatment in a patient with alopecia universalis
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Annual Convention in the Time of COVID
- Improvement of Recalcitrant Dissecting Cellulitis of the Scalp After a Trial of Upadacitinib
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- A Successful Treatment of Alopecia Universalis with Ruxolitinib
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Janus Kinase inhibitors in dermatology: a review
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Janus Kinase Inhibitors for Alopecia Areata
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- BH02 Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with the <i>AIRE</i> gene mutation treated with ruxolitinib
- Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata